Delivery Order SPE2DR25D2014-SPE2DR26FA0V8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100 count) with a ceiling value of $5,116.49. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of December 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $4,349.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with a completion date of July 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs, likely for military or veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,135.88. This non-competitive set-aside delivery order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete purchase order issued under a...
- The Defense Logistics Agency awarded a $2,768.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Isosorbide Dinitrate 40 mg tablets (100-count) on October 28, 2025, with an ultimate completion date of October 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of 100 units of Isosorbide Mononitrate 20 mg tablets. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm-fixed price of $1,399.99 and an ultimate completion date of April 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isosorbide Dinitrate 40 mg tablets (100 count) with a ceiling value of $3,383.38 under a firm fixed-price contract type. The award was issued on December 29, 2025, with an ultimate completion date of December 30, 2025, and represents a non-set-aside competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- This federal contract award, valued at $47,793.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,754,097 units of Isosorbide Dinitrate 40 mg tablets (100 per bottle). The contract has a completion date of February 26, 2024 and a potential value of $7,158.29. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $159,622.11 firm-fixed-price delivery order is for the supply of 4,537,317,586 units of Isosorbide 10mg tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support...
- This federal contract award, valued at $3,479.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,722,938 units of Isosorbide Dinitrate 40 mg tablets, a drug used for the treatment of cardiovascular conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0V8Delivery Order
The Defense Logistics Agency awarded a $2,708.10 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100 count). This competitive, non-set-aside contract carries a firm fixed price and is scheduled for completion by December 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX and extending through December 2026. The underlying IDC enables the contractor to supply a comprehensive portfolio of pharmaceuticals and medical supplies globally to support military healthcare operations. AmerisourceBergen's federal contract history demonstrates consistent success in meeting DLA requirements across multiple therapeutic domains, positioning the company as a primary vendor within the Defense Logistics Agency's pharmaceutical supply chain for the Department of Defense and affiliated federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/28/25 |